Kardigan KARD
NASDAQ KARD
$13.82 -0.30 (-2.12%)
At close: Nov 13, 2026 · 4:00 PM EST

Kardigan (KARD) Other Accumulated Expenses (2024 - 2026)

Updated

Kardigan (KARD) posted Other Accumulated Expenses of $3.72 million for Q3 2026, down 8.4% from the prior quarter.

Analysis

Kardigan (KARD) Other Accumulated Expenses (2024 - 2026) Analysis & Trends

At the end of FY2025, Kardigan's Other Accumulated Expenses came in at $3.27 million, up 318.7% from FY2024.

  • In prior years, Kardigan's Other Accumulated Expenses was $780,000 in FY2024.
  • Quarterly Other Accumulated Expenses has run from a low of $780,000 in Q4 2024 to a high of $4.06 million in Q2 2026 over five years.
  • According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $4.06 million (Q2 2026), $3.66 million (Q1 2026) and $3.27 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Kardigan 1.29 Bn -398.44 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.72 Mn
Jun 30, 2026 4.06 Mn
Mar 31, 2026 3.66 Mn
Dec 31, 2025 3.27 Mn
Dec 31, 2024 780,000.00
API Access

Kardigan Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=KARD&period=max&api_key=YOUR_API_KEY